ABSTRACT. Infantile Zellweger syndrome belongs to the group of peroxisomal disorders that lack peroxisomes. Both trihydroxycoprostanic acid (THCA), the precursor to cholic acid, and dihydroxycoprostanic acid (DHCA), the precursor to chenodeoxycholic acid, accumulate in this disease. In previous studies, we have shown that liver peroxisomes are required for the conversion of THCA into cholic acid both in vitro and in vivo by measuring a defective conversion in infants with Zellweger syndrome. In our present study, the conversion of DHCA into chenodeoxycholic acid has been measured in an infant with Zellweger syndrome to evaluate the importance of liver peroxisomes for the formation of chenodeoxycholic acid. Coprostanic acidemia was present from the second day of life with high levels of THCA and only trace amounts of DHCA. The conversion of i.v. administered 13H]DHCA into chenodeoxycholic acid was only 7% compared with the 80% conversion in an analogous study in an adult. There was, however, a rapid incorporation of 'H into biliary THCA and, after a lag phase, the 3H was incorporated into biliary cholic acid. After 72 h, 15% of 13H]DHCA was converted to cholic acid. The pool size of DHCA was 1.2 mg/m2 and the pool size of both cholic acid and chenodeoxycholic acid was markedly reduced. The renal excretion of cholic acid was more efficient than that of the less polar chenodeoxycholic acid. More polar metabolites of DHCA and THCA are formed in alternative metabolic pathways facilitating renal excretion of these toxic intermediates. We conclude that liver peroxisomes are essential for a normal conversion of DHCA into chenodeoxycholic acid. (Pediarr Res 29: 64-69, 1991) Abbreviations DHCA, 3a,7a-dihydroxycoprostanic acid (or 3a,7a-dihydroxy-50-cholestanoic acid) THCA, 3a,7a,l2a-trihydroxycoprostanic acid C2,-dicarboxylic acid, 3a,7a,12a-trihydroxy-27-carboxymethylcoprostanic acid GC-MS, gas chromatography-mass spectrometry
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Cholesterol is oxidized to cholic acid and chenodeoxycholic acid by enzymes localized to several subcellular compartments of the human hepatocyte (1). Recently in vitro and in vivo studies in man have indicated that intact liver peroxisomes are required for the oxidative cleavage of the side chain of THCA, the last step in the biosynthesis of cholic acid (2) (3) (4) (5) . The relative importance of liver peroxisomes in the formation of chenodeoxycholic acid is less well established. We have shown that the in vitro formation of chenodeoxycholic acid from DHCA is most efficiently catalyzed by the peroxisomal fraction of rat and human liver homogenates (3, 6 ). The accumulation of DHCA in the circulation of infants with Zellweger syndrome that are lacking liver peroxisomes (7, 8) is, however, often reported to be considerably lower than that of THCA (4, 5,9, 10). In addition, serum levels of chenodeoxycholic acid are often higher than those of cholic acid in the first weeks of life (4, 5, 9, 1 1). In a liver biopsy from a patient with Zellweger syndrome, there was at least a small formation of chenodeoxycholic acid from DHCA (5). In contrast, there was no detectable conversion of THCA into cholic acid (5) .
We have shown that the tritium label of [3H]7cr-hydroxy-4-cholesten-3-one, a common precursor to both cholic and chenodeoxycholic acid, was rapidly incorporated into both THCA and DHCA in an infant with Zellweger syndrome (5) . There was a very slow incorporation of radioactivity into both cholic acid and chenodeoxycholic acid. Due to the experimental design, however, no detailed quantitative information could be obtained with respect to formation of labeled chenodeoxycholic acid, but it was concluded that peroxisomes are important also in the normal biosynthesis of this bile acid. To more specifically study the role of peroxisomes in the biosynthesis of chenodeoxycholic acid in vivo, we administered [7P-)H]DHCA together with [I4C] chenodeoxycholic acid and [14C]cholic acid to an infant with Zellweger syndrome. We also measured the pool sizes of DHCA, chenodeoxycholic acid, and cholic acid.
PATIENT AND METHODS
Clinical. Three pregnancies preceded the present one. The first two resulted in two healthy girls. After the second pregnancy, the mother developed hypothyroidism and was treated with thyroxine. In 1982, a third girl was born with severe neurologic dysfunction, bilateral pes equino-varus, and stigmata similar to those in trisomy 21. She died when she was 2% mo old. At autopsy, neuronal migration arrest, liver fibrosis, and microcysts in renal cortex were found. A frozen sample of urine stored from this daughter contained high amounts of coprostanic acids, con-6 5 firming 2 y post-mortem the assumed diagnosis of Zellweger syndrome. The mother aborted spontaneously once before she delivered the infant described here.
The boy was delivered in 1984 at term by cesarean section because of maternal bleeding. He weighed 2350 g, was dysmature, hypotonic, and had craniofacial dysmorphic features as described for Zellweger syndrome. Bilateral pes equino-varus and corneal opacity with partial detachment of iris to cornea in the right eye were also observed in the perinatal period.
At 1 mo of age, he got convulsions and was treated with diazepam. Clinical signs of bile stasis occurred at the age of 6 wk with decoloring of the feces and darkening of the urine, but icterus was not visible. No other clinical signs of hepatic failure were observed. At the age of 3 mo, the infant died.
At autopsy, bilateral bronchopneumonia and microcysts in renal cortex were found. The liver was enlarged with a greenish surface. Bile plugs in bile canaliculi and intracellular bile pigment accumulation were widespread. ,There were no signs of cell necrosis in the liver parenchyma, no cirrhosis, and only slight fibrosis. In the CNS, heterotopias of both pyramidal cells and Purkinje cells were seen. Nucleus olivarius lacked its natural folding.
Laboratory findings in serum (reference data in parentheses) at the age of 4 d and 4 wk, respectively, were as follows: Hb, 22. Preparation of labeled s~eroids. [7P-3H]DHCA (50 Cilmol) was prepared as described (12) . [24-14C] :holic acid (0.36 x lo6 dpm) and [14C]chenodeoxycholic acid :0.42 x lo6 dpm) were dissolved in 0.5 mL of ethanol, filtered, ind slowly mixed into 5.5 mL of 20% human serum albumin. 9t the age of 8 wk, 5 mL of the mixture were given i.v. during 15 min. Duodenal intubation was performed and duodenal :ontents were sampled at least 2 h after each meal, at 2, 6, 12, !4, 48, and 72 h after the infusion. The amount of aspirated luodenal fluid was only 1-2 mL to avoid disturbances in the ,001s of the bile acids. Venous blood samples were drawn after !4,48, and 72 h. Urine was collected in four periods: 0-6,6-24, !4-48, and 48-72 h.
Analyses of serum, bile, and urine. The serum samples, (0.25 nL) were hydrolyzed under alkaline conditions to deamidate the ,ile acids. The acidic extraction desulfates the bile acids as lescribed previously (5, 13, 14) . To the serum samples used for s a y by isotope dilution-mass spectrometry, *H-labeled cholic .cid, chenodeoxycholic acid, and deoxycholic acid were added ~efore hydrolysis (13, 14) . The methyl ester trimethylsilyl ether lerivatives were prepared before combined GC-MS. An LKB 2091-051 GC-MS (LKB Instruments, Inc., Gaithersburg, MD) operating at 70 eV equipped with a four-channel multiple ion detector (LKB 209 1-7 10) was used. The capillary fused silica column (obtained from JW Scientific Inc., Folsom, CA) was 30 m x 0.25 mm and was coated with the midpolarity DB-1301 phase. Initial temperature was 180'C for 2 min followed by an increase of g0C/min up to 290°C. The above conditions were used for all identifications. For quantitations of the different bile acids, isothermal conditions were used under the same conditions as previously described in detail (4, 14). The approximate concentration of C29-dicarboxylic acid was determined from the tracing at m/z 253 (4, 5). The concentration of DHCA was determined by tracing the ion at m/z 4 12 (from DHCA) and the ion at m/z 374 (from 'H4-labeled chenodeoxycholic acid) with use of an appropriate standard curve.
The bile, serum, and urine samples, collected after the in vivo administration of radioactive compounds, and an aliquot of the infusate were hydrolyzed as above and extracted with Sep-Pak C 18 cartridges (Waters Associates, Millipore Corp., Milford, MA) after acidification. The cartridges were washed with 5-10 mL H 2 0 before elution with 10 mL methanol (15, 16) . Aliquots of the extracts were chromatographed on HPLC with a Zorbax octadecylchlorosilane column (5 x 250 mm, DuPont de Nemours & Co., Inc., Wilmington, DE) and 20% 30 mM trifluoroacetic acid adjusted to pH 2.9 with triethylamine in methanol as solvent (trifluoroacetic acid/triethylamine) at a flow rate of 0.5-1 mL/min. Aliquots of the fractions were evaporated and assayed for 'H and I4C as described previously (4). The recovery from the HPLC column was essentially complete. Fractions containing radioactivity were extracted on Sep-Pak C 18 cartridges after acidification as described. The extracts were converted to the methyl ester trimethylsilyl ether derivatives and analyzed by combined GC-MS as described above. The identity of the different C2, and Cz4 bile acids and the C29-dicarboxylic bile acid was Urine sample. Urine (2 L) collected before, during, and after the in vivo study, was mixed and extracted on SepPak C 18 cartridges after acidification (I 5). Full recovery of radioactivity was achieved. The extract was hydrolyzed and reextracted as above. Aliquots were chromatographed on HPLC using a 5-j~m Beckman Ultrasphere octadecylchlorosilane column (10 x 250 mm) and eluted as above. The more polar metabolites that appeared before cholic acid were reextracted and rechromatographed for better separation. Radioactive fractions occumng in the HPLC were extracted and derivatized before combined GC-MS.
RESULTS

Serum bile acids. The clinical diagnosis of Zellweger syndrome
was supported by measuring high levels of THCA in a blood sample drawn on the 2nd day of life (Table 1 ) (4). At this earl) stage, the serum level of C29-dicarboxylic acid was very low. Aftei 4 wk of age, however, the level of the Cz9-dicarboxylic acid hac increased considerably and was in fact the dominating copros. tanic acid in serum together with THCA. The serum levels o. the primary bile acids in man, cholic acid and chenodeoxycholic acid, were low on the 2nd day of life and continued to be lov compared to levels of age-matched controls (1 9) and to levels wc have measured in other infants with the Zellweger syndrome (4 25 mL) , 3a,7a,12a-trihydroxy-C29-dicarboxylic acid (14-15 mL), and 5b-cholestanoic acids with four hydroxyl groups in the steroid nucleus (6 and 9 mL). 5). The concentrations of DHCA were very low compared to those of THCA (Table 1) .
After the in vivo administration of [)H]DHCA, [14C]cholic acid, and [14C]chenodeoxycholic acid, serum samples were hydrolyzed, extracted, and subjected to HPLC. The HPLC profile of the 24-h serum extract is shown in Figure 1 . The least polar split peak (elution volume 41-49 mL) was shown to contain DHCA (R-and S-form). In this extract, [3H]DHCA accounted for 23% of the total recovered activity. In the 48-h extract it accounted for 18% and, after 72 h, 12% of the total tritium activity in serum was retained in DHCA. The material in the main split peak that eluted after 21-25 mL was identified as THCA by GC-MS (Fig. 1) . Still, after 48 h and 72 h, the peak containing THCA accounted for the main tritium activity, 34 and 30%, respectively. The minor peak at 17 mL contained both 3H-and I4C-labeled chenodeoxycholic acid and that at 10 mL, 3H-and I4C-labeled cholic acid. The compound corresponding to the peak that eluted at 13 mL was identified as 3a,7a, 12a-trihydroxy-C29-dicarboxylic acid. The peaks that eluted at 7-8 mL and 3-4 mL contained coprostanic acids with a tetrahydroxylated steroid nucleus (m/z 251 and The least polar split peak in the chromatogram contained DHCA. During the first 24 h, the tritium activity in the DHCA peak was mainly incorporated into the split peak at 21 mL containing THCA and into the peak at 16 mL containing chenodeoxycholic acid. Later, two more polar peaks occurred: the peak at 9.5 mL contained cholic acid and the peak at 6 mL contained a not yet identified compound. The peak that eluted at 12 mL contained 3a,7a, l2a,24-tetrahydroxycoprostanic acid and an unidentified compound. In the 72 h bile extract, the [3H] DHCA was still detectable (3% of total tritium activity of the radiogram). At that time, the major part of the 3H-activity appeared in the peaks that contained THCA and the unidentified compound at 6 mL and, to a lesser extent, in the peaks corresponding to chenodeoxycholic acid and cholic acid.
Both 3H-and I4C-activities were measured in the peaks containing chenodeoxycholic acid and cholic acid. The 'H/I4C ratio in these peaks was correlated to the -'H/I4C ratio in the infusate. The ratio of 'H-activity to that of I4C-activity recovered in the biliary chenodeoxycholic acid increased from 0 after 2 h to 1.6 after 72 h. At 72 h, the 'H/I4C ratio was 7% of that in the infused material, indicating that only about 7% of the DHCA had been converted into chenodeoxycholic acid in this patient (Fig. 3) . When the area under the sp act curve of [3H]chenodeoxycholic acid (derived from precursor) was divided by the area under the sp act curve of the [14C]chenodeoxycholic acid (17), the conversion of [3H]DHCA into [3H]chenodeoxycholic acid was calculated to be only 2%. In a similar study, an 80% conversion of DHCA into chenodeoxycholic acid after 12 h was found in an adult with bile fistula (20) .
The conversion of ['HIDHCA into ['H]cholic acid was more difficult to estimate due to the fact that ['Hlcholic acid was still synthesized after 72 h (Fig. 3) . At 72 h, the 'H/I4C ratio had increased to 3. Both DHCA and THCA accumulate as a consequence of impaired peroxisomal formation of chenodeoxycholic acid (III) and cholic acid (IV). THCA accumulates more than DHCA due to an efficient 12a-hydroxylase. The side chain of THCA is slowly elongated to a C29-dicarboxylic acid, which accumulates as a consequence of a slow renal excretion. The steroid nucleus and the side chain of THCA are efficiently hydroxylated. The tetrahydroxylated coprostanic acids formed are efficiently excreted to urine and thus accumulate to a small extent. 24 h (Fig. 4) . From the specific radioactivity decay curve of biliary ['4C]chenodeoxycholic acid and [14C]cholic acid (not shown), the pool size of chenodeoxycholic acid was calculated to be 1.1 mg (5.7 mg/m2) and the synthesis rate 0.6 mg/d (3.2 mg/ m2/24 h). The pool size of cholic acid was about 0.3 mg (1.5 mg/m2) and the synthesis rate only about 0.2 mg/24 h ( 1.1 mg/ m2/24 h) ( Table 2 ).
Renal excretion of 'H-and I4C-labeled bile acids. The urine samples collected between 0 and 6 h after infusion contained 1100 dpm of 'H and 960 dpm of I4C per mL. The relative recovery of I4C radioactivity to that of ' H decreased in the subsequent urine samples, and the 48-72 h sample contained 3700 dpm of 'H and 370 dpm of I4C per mL.
The HPLC profiles of the extracts of the three urine samples are shown in Figure 5 . DHCA was eluted between 40 and 50 mL, THCA between 20 and 25 mL, chenodeoxycholic acid between 16 and 17 mL, the 3a,7a, 12a-trihydroxy-C29-dicarboxylic acid at 14 mL, 3a,7a, 12a,24-tetrahydroxycoprostanic acid at 1 1 mL as a shoulder to the peak containing cholic acid at 10 mL (Fig. 5B) . The two most polar peaks at 9.5 mL and 6 mL both contained tetrahydroxylated Cz7-steroid acids with four hydroxyl groups in the steroid nucleus.
In the urine samples collected during the first 6 h after infusion, ['HIDHCA and ['HITHCA were the main peaks. Throughout the study, ['HITHCA continued to be the main peak, indicating an efficient excretion of this metabolite. There was also a high incorporation of 'H activity into the tetrahydroxylated C27 steroid with all hydroxyl groups in the steroid nucleus. The peak that eluted at 14 mL was small and unchanged throughout the study, indicating a slow renal excretion of the 3a,7a,12a-trihydroxyC2g-dicarboxylic acid.
The activity from [14C]cholic acid accounted for almost all of the I4C activity detected in the urine samples. Only trace amounts of [14C]chenodeoxycholic acid could be detected in the samples.
DISCUSSION
Zellweger syndrome was diagnosed clinically on the 1st day of our patient's life. The high levels of C29-dicarboxylic acid in serum and the high C:26/C:22 ratio in cultured fibroblasts were considered sufficient to exclude "Pseudo-Zellweger" and to confirm the diagnosis.
Zellweger syndrome with its lack of peroxisomes represents an attractive model to estimate the role of liver peroxisomes in vivo (5,2 1). High serum levels of THCA and to a lesser extent DHCA are constant findings. About 10% of THCA has been found to be converted into cholic acid under this pathologic condition (5) . This contrasts with the very efficient conversion obtained in previous analogous in vivo studies in adults (80-90% conversion) (17) and explains the very low pool sizes of cholic acid in infants with Zellweger syndrome compared to age-matched controls (22, 23) .
In our present in vivo study on the conversion of DHCA into primary bile acids in an infant with Zellweger syndrome, a 2-h bile sample contained 'H-labeled DHCA and THCA and I4C-labeled cholic and chenodeoxycholic acid, indicating a rapid hepatic uptake and biliary excretion despite clinical signs of bile stasis. As time passed, only a minor part of the tritium in the administered ['HIDHCA was incorporated into chenodeoxycholic acid. In addition, the course of incorporation was very slow, only about 3% after 12 h. This finding is in contrast to the 80% conversion of DHCA into chenodeoxycholic acid after 12 h in an adult with bile fistula (20) . The very low pool size of chenodeoxycholic acid, calculated from the sp act decay curve of biliary ['4C]chenodeoxycholic acid, supports the low formation of chenodeoxycholic acid. The pool size in this infant (5.7 mg/m2) was in fact only 3% of that of a 7-wk-old healthy infant in a previous study (23) . These findings strongly suggest that, in man, intact liver peroxisomes are required for a normal formation of chenodeoxycholic acid from DHCA.
Although serum and urine levels of bile and coprostanic acids vary with age and within the Zellweger population, the main part of the coprostanic acids, including the C29-dicarboxylic acid and the tetrahydroxylated acids, is 12a-hydroxylase. Serum levels of DHCA may vary considerably (24) , and probably reflect individual differences in activity of, or access of DHCA to, the 12a-hydroxylase. It is evident from the present and previous studies ( 3 , however, that the 12a-hydroxylation of DHCA into THCA is highly effective and represents the first step in the main 3. Kase acid. In contrastythe patient with a bile fistula incorporated only 2% of the tritium activity from administered [3H]DHCA into cholic acid (20) . In the metabolic defect found in our patient, the cholic acid formation pathway is relatively more important, allowing an increased excretion of toxic metabolites (25, 26). The course of cholic acid formation showed a lag phase of about 12 h, and the conversion was most rapid after 48 h when the formation of chenodeoxycholic acid leveled off (Fig. 3) . This may be due to a competition between DHCA and THCA for the same enzymes. A slow formation of THCA cannot explain the finding, inasmuch as THCA was detectable already in the 2-h bile sample and was the major labeled compound in the 6-h bile sample.
After 72 h, about 25% of the tritium label of ['HIDHCA had been incorporated into primary bile acids. Despite the ongoing cholic acid formation, it is evident that primary bile acids were only minor metabolites of [)H]DHCA.
Bile stasis has been observed previously in infants with Zellweger syndrome. In our patient, the bile stasis may explain the small pool size of cholic acid compared with those measured in previously studied infants with this syndrome (Table 2 ) (4, 5) . The uptake of bile acids from the portal vein to the hepatocytes is most probably impaired in bile stasis, allowing more of the bile acids to pass into the systemic circulation. According to the analyses of the urine samples, the renal clearance of ['4C]cholic acid seemed to be considerably higher than that of ['4C]chenodeoxycholic acid. This may contribute to the very low pool size of cholic acid compared with that of chenodeoxycholic acid.
To summarize, the present in vivo study has shown that the side-chain cleavage of DHCA into chenodeoxycholic acid is almost completely blocked in a patient with Zellweger syndrome. As a consequence, the pool size of chenodeoxycholic acid is markedly reduced. The major part of the accumulated DHCA is converted to THCA. The latter compound and unusual hydroxylated metabolites of this acid accumulate due to impaired conversion into cholic acid.
We can conclude from this and previous in vivo studies (4, 5) that liver peroxisomes are essential for a normal conversion of coprostanic acids into primary bile acids in man.
